Literature DB >> 9514094

Molecular analysis of two mammary carcinoma cell lines at the transcriptional level as a model system for progression of breast cancer.

S Schiemann1, M Schwirzke, N Brünner, U H Weidle.   

Abstract

As a model system for the identification of genes involved in the progression of human breast cancer, differential gene expression in cell lines MCF-7 and MCF-7ADR was investigated. The latter cell line is derived from the former. Cell line MCF-7 is estrogen receptor-positive, vimentin-negative and uninvasive in the Matrigel outgrowth assay and in the nude mouse, while MCF-7ADR is estrogen receptor-negative, hormone-resistant, vimentin-positive, invasive in the Matrigel outgrowth assay and in the nude mouse and resistant to adriamycin due to overexpression of glycoprotein gp170. We have shown that tumor progression in this model system is mediated by transcriptional regulation of mitochondria-related genes, proteases, transmembrane receptors and cell cycle-related gene proteins. Among the genes differentially regulated at the transcriptional level in the cell lines MCF-7 and MCF-7ADR are a new mitochondrial transcript, mitochondrial creatine kinase, matrix metalloproteinase-1, stromelysin-3, urokinase and its receptor, tissue factor, E-cadherin, epidermal growth factor receptor, transmembrane proteins Mat-8 and progression associated protein (PAP), cyclin E, cyclin-dependent kinase-2 and cell cycle inhibitory proteins p16, p21 and p27.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9514094     DOI: 10.1023/a:1021941203905

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  45 in total

1.  Two differentially expressed genes in normal human prostate tissue and in carcinoma.

Authors:  F L Wang; Y Wang; W K Wong; Y Liu; F J Addivinola; P Liang; L B Chen; P W Kantoff; A B Pardee
Journal:  Cancer Res       Date:  1996-08-15       Impact factor: 12.701

2.  Differential gene expression in human mammary carcinoma cells: identification of a new member of a receptor family.

Authors:  S Schiemann; M Rückels; L H Engelholm; M Schwirzke; N Brünner; U H Weidle
Journal:  Anticancer Res       Date:  1997 Jan-Feb       Impact factor: 2.480

3.  Sequence and organization of the human mitochondrial genome.

Authors:  S Anderson; A T Bankier; B G Barrell; M H de Bruijn; A R Coulson; J Drouin; I C Eperon; D P Nierlich; B A Roe; F Sanger; P H Schreier; A J Smith; R Staden; I G Young
Journal:  Nature       Date:  1981-04-09       Impact factor: 49.962

4.  p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21.

Authors:  H Toyoshima; T Hunter
Journal:  Cell       Date:  1994-07-15       Impact factor: 41.582

5.  Association of increased basement membrane invasiveness with absence of estrogen receptor and expression of vimentin in human breast cancer cell lines.

Authors:  E W Thompson; S Paik; N Brünner; C L Sommers; G Zugmaier; R Clarke; T B Shima; J Torri; S Donahue; M E Lippman
Journal:  J Cell Physiol       Date:  1992-03       Impact factor: 6.384

6.  CDK2 encodes a 33-kDa cyclin A-associated protein kinase and is expressed before CDC2 in the cell cycle.

Authors:  S J Elledge; R Richman; F L Hall; R T Williams; N Lodgson; J W Harper
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-01       Impact factor: 11.205

7.  Changes in the expression of matrix proteases and of the transcription factor c-Ets-1 during progression of precancerous bronchial lesions.

Authors:  I Bolon; E Brambilla; B Vandenbunder; C Robert; S Lantuejoul; C Brambilla
Journal:  Lab Invest       Date:  1996-07       Impact factor: 5.662

8.  Mat-8, a novel phospholemman-like protein expressed in human breast tumors, induces a chloride conductance in Xenopus oocytes.

Authors:  B W Morrison; J R Moorman; G C Kowdley; Y M Kobayashi; L R Jones; P Leder
Journal:  J Biol Chem       Date:  1995-02-03       Impact factor: 5.157

9.  Cyclin E, a potential prognostic marker for breast cancer.

Authors:  K Keyomarsi; N O'Leary; G Molnar; E Lees; H J Fingert; A B Pardee
Journal:  Cancer Res       Date:  1994-01-15       Impact factor: 12.701

10.  Epithelial membrane protein-1, peripheral myelin protein 22, and lens membrane protein 20 define a novel gene family.

Authors:  V Taylor; A A Welcher; A E Program; U Suter
Journal:  J Biol Chem       Date:  1995-12-01       Impact factor: 5.157

View more
  11 in total

1.  Prediction of gene function by genome-scale expression analysis: prostate cancer-associated genes.

Authors:  M G Walker; W Volkmuth; E Sprinzak; D Hodgson; T Klingler
Journal:  Genome Res       Date:  1999-12       Impact factor: 9.043

2.  Functional cloning of ARM-1, an adhesion-regulating molecule upregulated in metastatic tumor cells.

Authors:  A B Simins; H Weighardt; K M Weidner; U H Weidle; B Holzmann
Journal:  Clin Exp Metastasis       Date:  1999       Impact factor: 5.150

3.  Tissue factor as a novel target for treatment of breast cancer.

Authors:  Marion Cole; Michael Bromberg
Journal:  Oncologist       Date:  2013-01-03

4.  Phenotypic reversion or death of cancer cells by altering signaling pathways in three-dimensional contexts.

Authors:  Fei Wang; Rhonda K Hansen; Derek Radisky; Toshiyuki Yoneda; Mary Helen Barcellos-Hoff; Ole W Petersen; Eva A Turley; Mina J Bissell
Journal:  J Natl Cancer Inst       Date:  2002-10-02       Impact factor: 13.506

5.  Fxyd3 and Lgi4 expression in the adult mouse: a case of endogenous antisense expression.

Authors:  Fabian Runkel; Marion Michels; Thomas Franz
Journal:  Mamm Genome       Date:  2003-10       Impact factor: 2.957

6.  FXYD3: A Promising Biomarker for Urothelial Carcinoma.

Authors:  Zhongfa Zhang; See-Tong Pang; Katherine A Kasper; Chunyan Luan; Bill Wondergem; Fan Lin; Cheng-Keng Chuang; Bin Tean Teh; Ximing J Yang
Journal:  Biomark Insights       Date:  2011-02-15

7.  Identification and transcript analysis of a novel wallaby (Macropus eugenii) basal-like breast cancer cell line.

Authors:  Julie A Sharp; Sonia L Mailer; Peter C Thomson; Christophe Lefèvre; Kevin R Nicholas
Journal:  Mol Cancer       Date:  2008-01-07       Impact factor: 27.401

8.  MicroRNA-195 inhibits proliferation, invasion and metastasis in breast cancer cells by targeting FASN, HMGCR, ACACA and CYP27B1.

Authors:  Richa Singh; Vikas Yadav; Sachin Kumar; Neeru Saini
Journal:  Sci Rep       Date:  2015-12-03       Impact factor: 4.379

9.  Microparticles Mediate the Intercellular Regulation of microRNA-503 and Proline-Rich Tyrosine Kinase 2 to Alter the Migration and Invasion Capacity of Breast Cancer Cells.

Authors:  Joyce Gong; Frederick Luk; Ritu Jaiswal; Mary Bebawy
Journal:  Front Oncol       Date:  2014-08-15       Impact factor: 6.244

10.  The cell surface mucin podocalyxin regulates collective breast tumor budding.

Authors:  Marcia L Graves; Jane A Cipollone; Pamela Austin; Erin M Bell; Julie S Nielsen; C Blake Gilks; Kelly M McNagny; Calvin D Roskelley
Journal:  Breast Cancer Res       Date:  2016-01-22       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.